Treatment:Inject CAR T cells

2 trials

Sponsors

Huizhou Municipal Central Hospital

Conditions

Relapsed or refractory acute B-cell lymphomamultiple myeloma

Early Phase 1

A single-center, single-arm,unblinded clinical study for CD19+CXCR5 cells in patients with non-Hodgkin lymphoma

Active, not recruitingChiCTR2200058038

Huizhou Municipal Central HospitalRelapsed or refractory acute B-cell lymphoma

Start: 2022-03-30Updated: 2023-11-27

A single-arm, unblinded safety and efficacy of CAR-T therapy in patients with multiple myeloma clinical research

Active, not recruitingChiCTR2200058738

Huizhou Municipal Central Hospitalmultiple myeloma

Start: 2022-05-30Updated: 2024-01-14